HARVARD BIOSCIENCE, INC. Accounts Receivable, Allowance for Credit Loss
HARVARD BIOSCIENCE, INC. (HBIO) had Accounts Receivable, Allowance for Credit Loss of $199.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets
us-gaap:AllowanceForDoubtfulAccountsReceivable · last filed 2026-08-11
- 2026-06-30: Accounts Receivable, Allowance for Credit Loss $199.00K.
- 2026-03-31: Accounts Receivable, Allowance for Credit Loss $200.00K.
- 2025-12-31: Accounts Receivable, Allowance for Credit Loss $207.00K.
- 2025-09-30: Accounts Receivable, Allowance for Credit Loss $162.00K.
| Period end | Accounts Receivable, Allowance for Credit Loss | Accounts Receivable, Allowance for Credit Loss as first filed |
|---|---|---|
| 2026-06-30 | $199.00K 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $200.00K 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $207.00K 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $162.00K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $164.00K 10-Q · filed 2026-08-11 | |
| 2025-03-31 | $241.00K 10-Q · filed 2026-05-12 | |
| 2024-12-31 | $215.00K 10-Q · filed 2026-08-11 | |
| 2024-09-30 | $174.00K 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $177.00K 10-Q · filed 2025-08-11 | |
| 2024-03-31 | $127.00K 10-Q · filed 2025-05-12 | |
| 2023-12-31 | $160.00K 10-K · filed 2026-03-13 | |
| 2023-09-30 | $144.00K 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $191.00K 10-Q · filed 2024-11-08 | $154.00K 10-Q · filed 2024-08-08 |
| 2023-03-31 | $167.00K 10-Q · filed 2024-05-07 | |
| 2022-12-31 | $191.00K 10-K · filed 2025-03-14 | |
| 2022-09-30 | $179.00K 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $195.00K 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $136.00K 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $136.00K 10-K · filed 2024-03-07 | |
| 2021-09-30 | $138.00K 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $145.00K 10-Q · filed 2022-08-04 | |
| 2021-03-31 | $254.00K 10-Q · filed 2022-05-04 | |
| 2020-12-31 | $227.00K 10-K · filed 2023-03-09 | |
| 2020-09-30 | $293.00K 10-Q · filed 2021-11-05 | |
| 2020-06-30 | $290.00K 10-Q · filed 2021-08-06 | |
| 2020-03-31 | $297.00K 10-Q · filed 2021-05-07 | |
| 2019-12-31 | $325.00K 10-K · filed 2022-03-11 | |
| 2019-09-30 | $364.00K 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $370.00K 10-Q · filed 2020-08-10 | |
| 2019-03-31 | $341.00K 10-Q · filed 2020-05-08 | |
| 2018-12-31 | $332.00K 10-K/A · filed 2021-03-17 | |
| 2018-09-30 | $301.00K 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $521.00K 10-Q · filed 2019-08-08 | |
| 2018-03-31 | $234.00K 10-Q · filed 2019-05-08 | |
| 2017-12-31 | $193.00K 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |